Pik3ca-mutant Metastatic Breast Cancer
📧 Sign up to get email alerts when something new happens for Pik3ca-mutant Metastatic Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-01-02Clinical Trial Update: Alpelisib (BYL719) in Combination With Continued Endocrine Therapy Following Progression on Endocrine Therapy in Hormone Receptor Positive, HER2 Negative, PIK3CA Mutant Metastatic Breast Cancer [Phase 2]
Phase 2 trial evaluating alpelisib in combination with continued endocrine therapy after progression in HR-positive, HER2-negative, PIK3CA-m…